COMBINED PHARMACEUTICAL COMPOSITION OF CDK4/6 INHIBITOR AND AROMATASE INHIBITOR - CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD

Title:

COMBINED PHARMACEUTICAL COMPOSITION OF CDK4/6 INHIBITOR AND AROMATASE INHIBITOR

Document Type and Number:

WIPO Patent Application WO/2023/046200

Kind Code:

A1

Abstract:

The present disclosure relates to a combined pharmaceutical composition of a CDK4/6 inhibitor and an aromatase inhibitor, and the use thereof in the treatment of breast cancer. Compared with separate administration of any agent in the composition, the combined pharmaceutical composition of the present disclosure yields a better therapeutic effect on slowing tumor growth or even eliminating tumors.

More Like This:

WO/2020/132378	COMPOSITIONS AND METHODS OF TREATMENT FOR NEUROLOGICAL DISORDERS COMPRISING DEPRESSION
WO/2022/039460	IMIDAZOLQUINOLINE OR BENZOINDAZOLONE COMPOUND AND INTERMEDIATE FOR PREPARING SAME
WO/2003/024445	DRUGS COMPRISING COMBINATION OF ANTITHROMBOTIC AGENT WITH PYRAZOLONE DERIVATIVE

Inventors:

FENG FAN (CN)
YU DING (CN)
ZHANG XIQUAN (CN)
WANG YUETING (CN)

Application Number:

PCT/CN2022/121752

Publication Date:

March 30, 2023

Filing Date:

September 27, 2022

Export Citation:

Click for automatic bibliography generation Help

Assignee:

CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD (CN)

International Classes:

C07D231/56; A61K31/416; A61K31/44; A61K31/445; A61K31/506; A61P35/00; C07D401/14; C07D403/14

Domestic Patent References:

WO2016141881A1	2016-09-15
WO2016141881A1	2016-09-15

Foreign References:

CN107137408A	2017-09-08
US20160184311A1	2016-06-30

Attorney, Agent or Firm:

BEIJING SUNHOPE INTELLECTUAL PROPERTY LTD. (CN)

Download PDF:

View/Download PDF PDF Help

Previous Patent: LIVE BROADCAST INFORMATION PRESENTATION METHOD AND APPARATUS, AND ELECTRONIC DEVICE AND STORAGE MEDI...

Next Patent: GENETICALLY MODIFIED NON-HUMAN ANIMAL WITH HUMAN OR CHIMERIC GENES